Gender and age-related differences in Burkitt lymphoma - epidemiological and clinical data from The Netherlands

被引:57
作者
Boerma, EG [1 ]
van Imhoff, GW
Appel, IM
Veeger, NJGM
Kluin, PM
Kluin-Nelemans, JC
机构
[1] Univ Groningen, Ctr Med, Dept Haematol, Groningen, Netherlands
[2] Univ Groningen, Ctr Med, Acad Hosp Groningen, Dept Pathol & Lab Med, NL-9700 RB Groningen, Netherlands
[3] DCOG, The Hague, Netherlands
[4] Univ Groningen, Ctr Med, Trial Coordinat Ctr, Groningen, Netherlands
关键词
adult; Burkitt lymphoma; child; clinical presentation; extranodal; epidemiology; gender;
D O I
10.1016/j.ejca.2004.09.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although Burkitt's lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 (n = 203). Detailed clinical data from two treatment protocols were compared: one for adults up to the age of 65 years (n = 27) and one for children (n = 80). All slides of the two clinical studies were centrally reviewed which included immunophenotyping and when necessary breakpoint analysis of MYC/8q24. Only cases with an unambiguous diagnosis of BL (classical and atypical BL) were accepted. The age distribution of BL-patients showed a bimodal distribution with a peak at the paediatric age and a steady increase after approximately 60 years of age. Most of the patients were males (89% for children and 78% for adults) and only male patients showed this bimodality. Children more often had extranodal disease (81% vs. 59%), whereas adults more often had nodal disease (89% vs. 53%). Based on epidemiology and clinical presentation, the concept that BL is one disease should be re-challenged. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2781 / 2787
页数:7
相关论文
共 32 条
[1]   SMALL NON-CLEAVED FOLLICULAR CENTER CELL LYMPHOMA - CLINICOPATHOLOGIC COMPARISON OF BURKITT AND NON-BURKITT VARIANTS IN FINNISH MATERIAL [J].
AINE, R .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (10) :1179-+
[2]  
APRIL F, 2000, ICD O INT CLASSIFICA
[3]   Burkitt's lymphoma: new insights into molecular pathogenesis [J].
Bellan, C ;
Lazzi, S ;
De Falco, G ;
Nyongo, A ;
Giordano, A ;
Leoncini, L .
JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (03) :188-192
[4]   Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group Experience [J].
Cairo, MS ;
Sposto, R ;
Perkins, SL ;
Meadows, AT ;
Hoover-Regan, ML ;
Anderson, JR ;
Siegel, SE ;
Lones, MA ;
Tedeschi-Blok, N ;
Kadin, ME ;
Kjeldsberg, CR ;
Wilson, JF ;
Sanger, W ;
Morris, E ;
Krailo, MD ;
Finlay, JL .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (04) :660-670
[5]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[6]  
DIEBOLD J, 2001, WHO CLASSIFICATION T, V2, P181
[7]   Cell adhesion receptors in lymphoma dissemination [J].
Drillenburg, P ;
Pals, ST .
BLOOD, 2000, 95 (06) :1900-1910
[8]   Burkitt's lymphoma in Greek adults - A study of the Hellenic co-operative oncology group [J].
Economopoulos, T ;
Dimopoulos, MA ;
Foudoulakis, A ;
Nikolaidis, C ;
Tsatalas, C ;
Pectacides, D ;
Rontogianni, D ;
Papageorgiou, E ;
Fountzilas, G .
LEUKEMIA RESEARCH, 2000, 24 (12) :993-998
[9]  
Falini B, 1999, BLOOD, V93, P2697
[10]   Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: Validation in Burkitt lymphomas from three geographic regions [J].
Haralambieva, E ;
Schuuring, E ;
Rosati, S ;
van Noesel, C ;
Jansen, P ;
Appel, I ;
Guikema, J ;
Wabinga, H ;
Bleggi-Torres, LF ;
Lam, K ;
van den Berg, E ;
Mellink, C ;
van Zelderen-Bhola, S ;
Kluin, P .
GENES CHROMOSOMES & CANCER, 2004, 40 (01) :10-18